. Aspects of serum and sputum antibody in chronic airways obstruction. Immunoglobulin levels and precipitating antibody against a range of microbial antigens were measured in simultaneously collected serum and sputum samples from patients with chronic bronchitis (11), cystic fibrosis (9), bronchiectasis (9), and asthma (4). Sputum was prepared by dialysis and high-speed centrifugation methods.
between the detection rate in the sputum and serum. This, combined with the lack of correlation between sputum and serum immunoglobulins, lack of relationship between bronchial inflammation and sputum immunoglobulins, and the lack of IgM in the sputum suggested that the antibody and immunoglobulin were locally produced.
Sputum IgA (7S) in patients with chronic bronchitis was significantly lower (P<0 05) than that found in patients with cystic fibrosis and bronchiectasis. Significant differences (P<0-05) were also noted in serum IgG levels between patients with chronic bronchitis, bronchiectasis, and cystic fibrosis while serum IgM levels in patients with chronic bronchitis were significantly lower (P<0-05) when compared to serum levels in patients with cystic fibrosis.
The presence of precipitating antibody in the sputum raises the possibility that type III reactions may be important in the pathogenesis of these conditions.
The mechanisms of pathogenicity of microbial organisms in the respiratory tract, as in other areas of the body, are poorly understood (Smith, 1972) . Additionally, the extensive resident flora of the upper respiratory tract (Austrian, 1968) makes difficult the assessment of the significance of organisms isolated from the sputum. Studies of precipitating antibody in the serum of patients with chronic airways obstruction against certain bacterial antigens (May, 1975) have attempted to deal with this problem although the significance of these results (Tager and Speizer, 1975) is still not clear. Previous studies have shown that it is possible to detect immunoglobulins and antibody against microbial and other antigens in sputum (Biberfeld and Sterner, 1971; Medici and Buergi, 1971; Falk, Okinaka, and Siskind, 1972; Gump et al., 1973; Ryley and Brogan, 1973; Shore, Potter, and Stuart-Harris, 1973;  Deuschl and Johansson, 1974; Wallwork et al., 1974; Warren and Tse, 1974; Brogan et al., 1975; Clarke, 1975) .
Bacterial infection of the lower respiratory tract is known to be frequent in chronic bronchial disorders such as chronic bronchitis, bronchiectasis, and cystic fibrosis whereas the normal bronchial tree is known to be sterile (Brumfitt, Willoughby, and Bromley, 1957; Lees and McNaught, 1959) . This suggests that there may be an abnormality of respiratory defences in patients with these conditions.
The aim of the present study was to determine the immunoglobulin content and antibody response of patients with chronic airways obstruction against microbial antigens as measured in simultaneously collected sputum and serum samples in order to determine if these measurements would provide insight into the mechanisms of bacterial pathogenicity in these conditions.
(9), and asthma (4) May (1972a (Ryley and Brogan, 1968) . The supernatant sol phase was stored with sodium azide at 4°C until tested. The sediment or gel phase was homogenized with Pancreatin (BDH Biochemicals, Poole) from pig pancreas and cultured (May, 1972b) .
2. The remainder of the sample was then diluted with three times its volume of distilled water and dialysed against distilled water, with frequent changes, at 4°C for 72 hours. Following this the dialysate was centrifuged at 10 000 rpm at 4°C for 30 minutes in an MSE 18 centrifuge. The supernatant was collected and freeze dried. This material was then stored at 4°C until tested (Longbottom, personal communication, 1973) .
Immunoglobulin estimations were performed by radial diffusion using commercially available plates (Behringwerke, AG). Low level plates were used for the estimation of sputum IgA (7S) and IgM. Precipitating antibody was detected using gel immunodiffusion techniques, as recommended by May (1972c) . Freeze-dried sputum preparations were reconstituted at 60 mg/ml in normal saline; preparations prepared by highspeed centrifugation were used without modification. Reconstituted sputum could not be used for quantitative estimation of sputum immunoglobulin. Bacterial and fungal antigens used in this study were as described previously (Clarke, 1975) . Antigen concentrations are listed in Table I . The chi square test (Colton, 1974) was used to analyse the relationship between the presence of precipitating antibody and sputum purulence. The Mann-Whitney U statistic (Meredith, 1967) was used to compare sputum and serum immunoglobulin levels in the various disease groups while the coefficient of correlation (Colton, 1974) was calculated for the relationship of serum to sputum immunoglobulins. These levels were first ranked in descending order of magnitude, and the coefficient was calculated from these. Means were calculated for immunoglobulin levels in the different disease groups. However, in some groups, values were truncated and in these the medians were calculated.
RESULTS
The overall results of the precipitating antibody studies are summarized in Table II , which lists the number of times a particular organism was isolated from the sputum, the number of patients with precipitating antibody in the sputum against the antigens used (which represents the total for both methods), and the number of patients with precipitating antibody in the serum against these same antigens. In Table III Cystic fibrosis (9) 6 9 9 Bronchiectasis (9) 5 5 7
Asthma (4) 0 1 1 tating antibody detected against the same antigen in the sputum. This discrepancy is also noted between sputum and serum antibody. This latter situation is summarized in Table IV.  Table V summarizes immunoglobulin estimations made on sputum and matching serum samples in the disease groups. It is appreciated that, by estimating 7S IgA only, the total amount of IgA present in the sputum is underestimated. Cystic Fibrosis (9) Bronchiectasis ( 
DISCUSSION
A problem with any study on sputum is to decide what contribution is made to the results by serum transudation, and formulae have been derived to estimate this (Deuschl and Johansson, 1974 This study confirms the finding in a previous study that precipitating antibody may be detected against bacterial and fungal antigens in the sputum (Clarke, 1975) . Detection of precipitating antibody against bacterial antigens in the serum of patients with these diseases has led some investigators to attach pathogenic significance to certain organisms that may be isolated from the sputum in these diseases (May, 1975) . It is often difficult in an individual patient to assess the pathogenic significance of an organism isolated from a sample of sputum at a given time. A search for sputum precipitins may facilitate this assessment. Support for this idea comes from a study of precipitating antibody to other inhaled antigens, viz, chicken antigens. It was shown by bronchial challenge testing that the antigens against which sputum precipitating antibody was directed had more relevance clinically than those against which serum antibody was directed (Warren and Tse, 1974) . A study of cystic fibrosis patients also demonstrated higher titres of sputum than of serum precipitins to certain antigens (Wallwork et al., 1974) .
The detection of precipitating antibody to bacterial antigen in sputum raises the possibility that type III or Arthus reactions could play a part in these conditions, as has been demonstrated for Aspergillus fumigatus (Katz and Kniker, 1973) . In support of this was the demonstration of extensive deposits of immunoglobulins and complement immune complexes in the respiratory tract of patients with cystic fibrosis (McFarlane et al., 1975) .
It is apparent from this study that the antigens used in the detection of precipitating antibody are of importance. Certainly with Pseudomonas aeruginosa and, to a lesser extent, Haemophilus influenzae it is the cell wall antigen that appears to have more relevance. This may be one reason why precipitating antibody was not detected against Ps. aeruginosa in a study of the sputum of patients with cystic fibrosis (Wallwork et al., 1974) .
As the method of preparation of the cell wall antigen is the same as that for the preparation of endotoxin and the cell wall and cytoplasmic antigens of H. influenzae have been shown to contain endotoxin (Branefors-Helander, 1973; Van Der Zwan, Orie, and De Vries, 1975 ) the detection of precipitating antibody to these antigens suggests that endotoxin is being released into the bronchial tree. This may contribute to the pathological processes by activation of the alternate pathway for complement (Gotze and MullerEberhard, 1971) , recruitment (Wittels et al., 1974) and pulmonary intravascular sequestration of leucocytes (Kilburn et al., 1974) , increasing vascular permeability, allowing inhaled antigens access to the circulation (Parish, 1972) , releasing and causing de novo synthesis of histamine directly (Szetivanyi, 1971 ) with subsequent mucous hypersecretion and mucosal oedema (Brocklehurst, 1970) , and increased bronchial reactivity in a similar manner to that produced by the endotoxin of Bordetella pertussis in experimental animals (Reed, 1968) .
The immunoglobulin results are of interest. The low IgA (7S) in the sputum of patients with chronic bronchitis compared to the other disease states raises the possibility that its production in chronic bronchitis may be abnormal, as suggested elsewhere (Medici and Buergi, 1971) . The lack of IgM in the sputum is supported by other studies (Falk et al., 1972; Gump et al., 1973) while the presence of IgG and IgA (7S) in the sputum of patients with bronchiectasis and cystic fibrosis gives further support to the concept that a defect of local immunoglobulin production is probably not the cause of the chronic infection seen in these conditions (Martinez-Tello, Braun, and Blane, 1968) . The significant differences in the sputum and serum immunoglobulins in the different disease states reported here may reflect a difference in the severity of the infection or a difference in the capacity to react to infection.
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